Zobrazeno 1 - 5
of 5
pro vyhledávání: '"borderline resectable pancreatic cancers"'
Autor:
Morgan Michalet, Karl Bordeau, Marie Cantaloube, Simon Valdenaire, Pierre Debuire, Sebastien Simeon, Fabienne Portales, Roxana Draghici, Marc Ychou, Eric Assenat, Marie Dupuy, Sophie Gourgou, Pierre-Emmanuel Colombo, Sebastien Carrere, François-Regis Souche, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionStereotactic MR-guided adaptive radiotherapy (SMART) is an attractive modality of radiotherapy for pancreatic tumors. The objectives of this prospective registry study were to report the dosimetric benefits of daily adaptation of SMART an
Externí odkaz:
https://doaj.org/article/b2d42a59afb44ee58e4fd9c3c5a46e5d
Autor:
Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaillé, Fabienne Portales, Roxana Draghici, Marc Ychou, Eric Assenat, Thibault Mazard, Emmanuelle Samalin, Ludovic Gauthier, Pierre-Emmanuel Colombo, Sebastien Carrere, François-Régis Souche, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 7
Introduction: Stereotactic MR-guided Adaptive RadioTherapy (SMART) is a novel process to treat pancreatic tumors. We present an update of the data from our prospective registry of SMART for pancreatic tumors. Materials and methods: After the establis
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bordeau K; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Michalet M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Portales F; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ychou M; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Assenat E; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Mazard T; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Samalin E; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Gauthier L; Biometrics Unit, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Colombo PE; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Carrere S; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Souche FR; Surgical Department, CHU St. Eloi, 34000 Montpellier, France., Aillères N; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Fenoglietto P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Dec 20; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 20.